부산대학교 도서관

Bastick, Patricia; Sewak, Sanjeev; Tran, Ben; Pichler, Martin; Shariat, Shahrokh; Rottey, Sylvie; Schatteman, Peter; Schrijvers, Dirk; Verschaeve, Vincent; Vulsteke, Christof; Barros Leite Ferreira, Luiza Aleixo; de Santana Gomes Andrea Juliana, Pereira; Junior, Joao Antonio; Azevedo, Sergio; Bastos, Diogo; Borges, Giuliano; Dettino, Aldo; Antonio, Pires Luis; Luz, Murilo; Martins, Suelen; Mota, Jose Mauricio; Toledo, Joseane; Eigl, Bernhard; Finch, Daygen; Gingerich, Joel; Dong, Haiying; Huang, Jian; Jin, Jie; Pan, Hongming; Sun, Zhongquan; Tian, Ye; Wan, Ben; Wu, Bin; Xu, Ting; Xue, Wei; Zhou, Fangjian; Barthelemy, Philippe; Borchiellini, Delphine; Calcagno, Fabien; Carnot, Aurelien; Cornillon, Pierre; Delva, Remy; Emambux, Sheik; Houede, Nadine; Laguerre, Brigitte; Lauridant, Géraldine; Loriot, Yohann; Mahammedi, Hakim; Maillet, Denis; Pouessel, Damien; Roubaud, Guilhem; Schlurmann-Constans, Friederike; Tosi, Diego; Zanetta, Sylvie; Banek, Severine; Feyerabend, Susan; Kramer, Mario; Niegisch, Guenther; Nuhn, Philipp; Schnabel, Marco; Wuelfing, Christian; Baka, Sofia; Bamias, Aristotelis; Fountzilas, George; Kalofonos, Harabolos; Karalis, Konstantinos; Kotsakis, Athanasios; Timotheadou, Eleni; Landherr, Laszlo; Mangel, Laszlo; Pe’er, Avivit; Levratovsky, Meital; Basso, Umberto; Battelli, Nicola; Cavo, Alessia; De Giorgi, Ugo; Doni, Laura; Galli, Luca; Gigante, Maria Olga; Guadalupi, Valentina; Maio, Michele; Milesi, Laura; Nolè, Franco; Scagliotti, Giorgio; Tortora, Giampaolo; Fukasawa, Satoshi; Harabayashi, Toru; Kamiya, Naoto; Kawahara, Takashi; Kawakita, Mutsushi; Matsubara, Nobunaki; Matsumoto, Kazumasa; Nishimura, Kazuo; Rikiya, Taoka; Shimizu, Nobuaki; Tagaki, Toshio; Kang, Taek Won; Kim, Jwa Hoon; Kim, SeHyun; Lee, Hyo Jin; Lee, Yun-Gyoo; Rha, Sun Young; Seo, Ho Kyung; Los, Maartje; Zurawski, Bogdan; Cortes, Paulo; Faustino, Catia; Vau, Nuno Sineiro; da Luz, Ricardo; Atduev, Vagif; Kirtbaya, Dmitry; Kopyltsov, Evgeny; Lykov, Aleksandr; Marat, Urmantsev; Orlov, Sergey; Penkov, Konstantin; Pirmagomedov, Albert; Semenov, Andrey; Varlamov, Sergey; Anguera, Georgia; Domenech, Montserrat; Girones, Regina; Gonzalez del Alba, Aranzazu; Milagro, Nuria Lainez; Luque, Raquel; Ortega, Esther Martínez; Mellado, Begoña; Méndez Vidal, María Jose; Fernandez, Esteban Nogales; Valderrama, Begoña Perez; Marín, Alvaro Pinto; Santander, Carmen; Huang, Yi-Hsiu; Su, Wen-Pin; Wu, Hung-Chan; Wu, WenJeng; Yu, Kai-Jie; Bilici, Ahmet; Goker, Erdem; Gumus, Mahmut; Karaoglu, Aziz; Kefeli, Umut; Köse, Fatih; Ozguroglu, Mustafa; Tural, Deniz; Turk, Haci; Yalcin, Suayib; Bondarenko, Igor; Khareba, Gennadii; Kidik, Yana; Lychkovskyy, Oleksandr; Sakalo, Valerii; Shevnia, Serghii; Stakhovskyy, Eduard; Bahl, Amit; Crabb, Simon; Powles, Thomas; Sankey, Peter; Sarwar, Mohammad; Benedetto, Pasquale; Burgess, Earle; Dawson, Nancy; Doshi, Gurjyot; Fleming, Mark; Maly, Joseph; Parikh, Mamta; Waterhouse, David; Siefker-Radtke, A.O.; Matsubara, N.; Park, S.H.; Huddart, R.A.; Burgess, E.F.; Özgüroğlu, M.; Valderrama, B.P.; Laguerre, B.; Basso, U.; Triantos, S.; Akapame, S.; Kean, Y.; Deprince, K.; Mukhopadhyay, S.; Loriot, Y.

In Annals of Oncology January 2024 35(1):107-117

Siefker-Radtke, A. O.; Matsubara, N.; Park, S. H.; Huddart, R. A.; Burgess, E. F.; Ozguroglu, M.; Valderrama, B. P.; Laguerre, B.; Basso, U.; Triantos, S.; Akapame, S.; Kean, Y.; Deprince, K.; Mukhopadhyay, S.; Loriot, Y.; Bastick, P.; Sewak, S.; Tran, B.; Pichler, M.; Shariat, S.; Rottey, S.; Schatteman, P.; Schrijvers, D.; Verschaeve, V.; Vulsteke, C.; Barros Leite Ferreira, L. A.; de Santana Gomes Andrea Juliana, P.; Junior, J. A.; Azevedo, S.; Bastos, D.; Borges, G.; Dettino, A.; Antonio, P. L.; Luz, M.; Martins, S.; Mota, J. M.; Toledo, J.; Eigl, B.; Finch, D.; Gingerich, J.; Dong, H.; Huang, J.; Jin, J.; Pan, H.; Sun, Z.; Tian, Y.; Wan, B.; Wu, B.; Xu, T.; Xue, W.; Zhou, F.; Barthelemy, P.; Borchiellini, D.; Calcagno, F.; Carnot, A.; Cornillon, P.; Delva, R.; Emambux, S.; Houede, N.; Lauridant, G.; Mahammedi, H.; Maillet, D.; Pouessel, D.; Roubaud, G.; Schlurmann-Constans, F.; Tosi, Domiziano Dario; Zanetta, S.; Banek, S.; Feyerabend, S.; Kramer, M.; Niegisch, G.; Nuhn, P.; Schnabel, M.; Wuelfing, C.; Baka, S.; Bamias, A.; Fountzilas, G.; Kalofonos, H.; Karalis, K.; Kotsakis, A.; Timotheadou, E.; Landherr, L.; Mangel, L.; Pe'Er, A.; Levratovsky, M.; Battelli, N.; Cavo, A.; De Giorgi, U.; Doni, L.; Galli, L.; Gigante, M. O.; Guadalupi, V.; Maio, M.; Milesi, L.; Nole, F.; Scagliotti, G.; Tortora, Giampaolo; Fukasawa, S.; Harabayashi, T.; Kamiya, N.; Kawahara, T.; Kawakita, M.; Matsumoto, K.; Nishimura, K.; Rikiya, T.; Shimizu, N.; Tagaki, T.; Kang, T. W.; Kim, J. H.; Kim, S.; Lee, H. J.; Lee, Y. -G.; Rha, S. Y.; Seo, H. K.; Los, M.; Zurawski, B.; Cortes, P.; Faustino, C.; Vau, N. S.; da Luz, R.; Atduev, V.; Kirtbaya, D.; Kopyltsov, E.; Lykov, A.; Marat, U.; Orlov, S.; Penkov, K.; Pirmagomedov, A.; Semenov, A.; Varlamov, S.; Anguera, G.; Domenech, M.; Girones, R.; Gonzalez del Alba, A.; Milagro, N. L.; Luque, R.; Ortega, E. M.; Mellado, B.; Mendez Vidal, M. J.; Fernandez, E. N.; Marin, A. P.; Santander, C.; Huang, Y. -H.; Su, W. -P.; Wu, H. -C.; Wu, W.; Yu, K. -J.; Bilici, A.; Goker, E.; Gumus, M.; Karaoglu, A.; Kefeli, U.; Kose, F.; Tural, D.; Turk, H.; Yalcin, S.; Bondarenko, I.; Khareba, G.; Kidik, Y.; Lychkovskyy, O.; Sakalo, V.; Shevnia, S.; Stakhovskyy, E.; Bahl, A.; Crabb, S.; Powles, T.; Sankey, P.; Sarwar, M.; Benedetto, P.; Burgess, E.; Dawson, N.; Doshi, G.; Fleming, M.; Maly, J.; Parikh, M.; Waterhouse, D.; Tosi D.; Tortora G. (ORCID:0000-0002-1378-4962)

Zhu W; Janssen Research & Development, Raritan, NJ, USA.; Baig M; Janssen Research & Development, Bridgewater, NJ, USA.; Naini V; Janssen Research & Development, San Diego, CA, USA.; De Meulder M; Janssen Research & Development, Beerse, Belgium.; Akapame S; Janssen Research & Development, Raritan, NJ, USA.; De Zwart L; Janssen Research & Development, Beerse, Belgium.; Haddish-Berhane N; Janssen Research & Development, Spring House, PA, USA.; Triantos S; Janssen Research & Development, Spring House, PA, USA.

Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2160-7648 (Electronic) Linking ISSN: 2160763X NLM ISO Abbreviation: Clin Pharmacol Drug Dev Subsets: MEDLINE

Loriot Y; From the Department of Cancer Medicine, INSERM Unité 981, Gustave Roussy, Université Paris-Saclay, Villejuif (Y.L.), the Department of Medical Oncology, Institut de Cancérologie du Gard, Centre Hospitalier Universitaire Caremeau, Nîmes (N.H.), and Montpellier University, Montpellier (N.H.) - all in France; the Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan (N.M.); the Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine (S.H.P.), and Seoul National University Hospital (J.H.K.) - both in Seoul, South Korea; the Section of Radiotherapy and Imaging, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom (R.A.H.); Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC (E.F.B.); the Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany (S.B.); the Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (V.G.); the Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain (B.P.V.); the Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.T.); Janssen Research and Development, Spring House, PA (S.T., Y.K., S.A., N.L.S.); Janssen Research and Development, Beerse, Belgium (K.D.); Janssen Research and Development, Raritan, NJ (S.M.); and the Department of Genitourinary Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston (A.O.S.-R.).; Matsubara N; From the Department of Cancer Medicine, INSERM Unité 981, Gustave Roussy, Université Paris-Saclay, Villejuif (Y.L.), the Department of Medical Oncology, Institut de Cancérologie du Gard, Centre Hospitalier Universitaire Caremeau, Nîmes (N.H.), and Montpellier University, Montpellier (N.H.) - all in France; the Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan (N.M.); the Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine (S.H.P.), and Seoul National University Hospital (J.H.K.) - both in Seoul, South Korea; the Section of Radiotherapy and Imaging, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom (R.A.H.); Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC (E.F.B.); the Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany (S.B.); the Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (V.G.); the Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain (B.P.V.); the Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.T.); Janssen Research and Development, Spring House, PA (S.T., Y.K., S.A., N.L.S.); Janssen Research and Development, Beerse, Belgium (K.D.); Janssen Research and Development, Raritan, NJ (S.M.); and the Department of Genitourinary Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston (A.O.S.-R.).; Park SH; From the Department of Cancer Medicine, INSERM Unité 981, Gustave Roussy, Université Paris-Saclay, Villejuif (Y.L.), the Department of Medical Oncology, Institut de Cancérologie du Gard, Centre Hospitalier Universitaire Caremeau, Nîmes (N.H.), and Montpellier University, Montpellier (N.H.) - all in France; the Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan (N.M.); the Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine (S.H.P.), and Seoul National University Hospital (J.H.K.) - both in Seoul, South Korea; the Section of Radiotherapy and Imaging, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom (R.A.H.); Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC (E.F.B.); the Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany (S.B.); the Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (V.G.); the Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain (B.P.V.); the Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.T.); Janssen Research and Development, Spring House, PA (S.T., Y.K., S.A., N.L.S.); Janssen Research and Development, Beerse, Belgium (K.D.); Janssen Research and Development, Raritan, NJ (S.M.); and the Department of Genitourinary Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston (A.O.S.-R.).; Huddart RA; From the Department of Cancer Medicine, INSERM Unité 981, Gustave Roussy, Université Paris-Saclay, Villejuif (Y.L.), the Department of Medical Oncology, Institut de Cancérologie du Gard, Centre Hospitalier Universitaire Caremeau, Nîmes (N.H.), and Montpellier University, Montpellier (N.H.) - all in France; the Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan (N.M.); the Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine (S.H.P.), and Seoul National University Hospital (J.H.K.) - both in Seoul, South Korea; the Section of Radiotherapy and Imaging, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom (R.A.H.); Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC (E.F.B.); the Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany (S.B.); the Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (V.G.); the Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain (B.P.V.); the Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.T.); Janssen Research and Development, Spring House, PA (S.T., Y.K., S.A., N.L.S.); Janssen Research and Development, Beerse, Belgium (K.D.); Janssen Research and Development, Raritan, NJ (S.M.); and the Department of Genitourinary Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston (A.O.S.-R.).; Burgess EF; From the Department of Cancer Medicine, INSERM Unité 981, Gustave Roussy, Université Paris-Saclay, Villejuif (Y.L.), the Department of Medical Oncology, Institut de Cancérologie du Gard, Centre Hospitalier Universitaire Caremeau, Nîmes (N.H.), and Montpellier University, Montpellier (N.H.) - all in France; the Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan (N.M.); the Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine (S.H.P.), and Seoul National University Hospital (J.H.K.) - both in Seoul, South Korea; the Section of Radiotherapy and Imaging, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom (R.A.H.); Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC (E.F.B.); the Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany (S.B.); the Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (V.G.); the Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain (B.P.V.); the Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.T.); Janssen Research and Development, Spring House, PA (S.T., Y.K., S.A., N.L.S.); Janssen Research and Development, Beerse, Belgium (K.D.); Janssen Research and Development, Raritan, NJ (S.M.); and the Department of Genitourinary Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston (A.O.S.-R.).; Houede N; From the Department of Cancer Medicine, INSERM Unité 981, Gustave Roussy, Université Paris-Saclay, Villejuif (Y.L.), the Department of Medical Oncology, Institut de Cancérologie du Gard, Centre Hospitalier Universitaire Caremeau, Nîmes (N.H.), and Montpellier University, Montpellier (N.H.) - all in France; the Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan (N.M.); the Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine (S.H.P.), and Seoul National University Hospital (J.H.K.) - both in Seoul, South Korea; the Section of Radiotherapy and Imaging, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom (R.A.H.); Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC (E.F.B.); the Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany (S.B.); the Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (V.G.); the Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain (B.P.V.); the Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.T.); Janssen Research and Development, Spring House, PA (S.T., Y.K., S.A., N.L.S.); Janssen Research and Development, Beerse, Belgium (K.D.); Janssen Research and Development, Raritan, NJ (S.M.); and the Department of Genitourinary Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston (A.O.S.-R.).; Banek S; From the Department of Cancer Medicine, INSERM Unité 981, Gustave Roussy, Université Paris-Saclay, Villejuif (Y.L.), the Department of Medical Oncology, Institut de Cancérologie du Gard, Centre Hospitalier Universitaire Caremeau, Nîmes (N.H.), and Montpellier University, Montpellier (N.H.) - all in France; the Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan (N.M.); the Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine (S.H.P.), and Seoul National University Hospital (J.H.K.) - both in Seoul, South Korea; the Section of Radiotherapy and Imaging, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom (R.A.H.); Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC (E.F.B.); the Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany (S.B.); the Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (V.G.); the Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain (B.P.V.); the Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.T.); Janssen Research and Development, Spring House, PA (S.T., Y.K., S.A., N.L.S.); Janssen Research and Development, Beerse, Belgium (K.D.); Janssen Research and Development, Raritan, NJ (S.M.); and the Department of Genitourinary Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston (A.O.S.-R.).; Guadalupi V; From the Department of Cancer Medicine, INSERM Unité 981, Gustave Roussy, Université Paris-Saclay, Villejuif (Y.L.), the Department of Medical Oncology, Institut de Cancérologie du Gard, Centre Hospitalier Universitaire Caremeau, Nîmes (N.H.), and Montpellier University, Montpellier (N.H.) - all in France; the Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan (N.M.); the Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine (S.H.P.), and Seoul National University Hospital (J.H.K.) - both in Seoul, South Korea; the Section of Radiotherapy and Imaging, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom (R.A.H.); Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC (E.F.B.); the Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany (S.B.); the Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (V.G.); the Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain (B.P.V.); the Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.T.); Janssen Research and Development, Spring House, PA (S.T., Y.K., S.A., N.L.S.); Janssen Research and Development, Beerse, Belgium (K.D.); Janssen Research and Development, Raritan, NJ (S.M.); and the Department of Genitourinary Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston (A.O.S.-R.).; Ku JH; From the Department of Cancer Medicine, INSERM Unité 981, Gustave Roussy, Université Paris-Saclay, Villejuif (Y.L.), the Department of Medical Oncology, Institut de Cancérologie du Gard, Centre Hospitalier Universitaire Caremeau, Nîmes (N.H.), and Montpellier University, Montpellier (N.H.) - all in France; the Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan (N.M.); the Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine (S.H.P.), and Seoul National University Hospital (J.H.K.) - both in Seoul, South Korea; the Section of Radiotherapy and Imaging, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom (R.A.H.); Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC (E.F.B.); the Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany (S.B.); the Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (V.G.); the Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain (B.P.V.); the Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.T.); Janssen Research and Development, Spring House, PA (S.T., Y.K., S.A., N.L.S.); Janssen Research and Development, Beerse, Belgium (K.D.); Janssen Research and Development, Raritan, NJ (S.M.); and the Department of Genitourinary Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston (A.O.S.-R.).; Valderrama BP; From the Department of Cancer Medicine, INSERM Unité 981, Gustave Roussy, Université Paris-Saclay, Villejuif (Y.L.), the Department of Medical Oncology, Institut de Cancérologie du Gard, Centre Hospitalier Universitaire Caremeau, Nîmes (N.H.), and Montpellier University, Montpellier (N.H.) - all in France; the Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan (N.M.); the Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine (S.H.P.), and Seoul National University Hospital (J.H.K.) - both in Seoul, South Korea; the Section of Radiotherapy and Imaging, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom (R.A.H.); Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC (E.F.B.); the Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany (S.B.); the Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (V.G.); the Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain (B.P.V.); the Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.T.); Janssen Research and Development, Spring House, PA (S.T., Y.K., S.A., N.L.S.); Janssen Research and Development, Beerse, Belgium (K.D.); Janssen Research and Development, Raritan, NJ (S.M.); and the Department of Genitourinary Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston (A.O.S.-R.).; Tran B; From the Department of Cancer Medicine, INSERM Unité 981, Gustave Roussy, Université Paris-Saclay, Villejuif (Y.L.), the Department of Medical Oncology, Institut de Cancérologie du Gard, Centre Hospitalier Universitaire Caremeau, Nîmes (N.H.), and Montpellier University, Montpellier (N.H.) - all in France; the Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan (N.M.); the Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine (S.H.P.), and Seoul National University Hospital (J.H.K.) - both in Seoul, South Korea; the Section of Radiotherapy and Imaging, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom (R.A.H.); Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC (E.F.B.); the Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany (S.B.); the Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (V.G.); the Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain (B.P.V.); the Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.T.); Janssen Research and Development, Spring House, PA (S.T., Y.K., S.A., N.L.S.); Janssen Research and Development, Beerse, Belgium (K.D.); Janssen Research and Development, Raritan, NJ (S.M.); and the Department of Genitourinary Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston (A.O.S.-R.).; Triantos S; From the Department of Cancer Medicine, INSERM Unité 981, Gustave Roussy, Université Paris-Saclay, Villejuif (Y.L.), the Department of Medical Oncology, Institut de Cancérologie du Gard, Centre Hospitalier Universitaire Caremeau, Nîmes (N.H.), and Montpellier University, Montpellier (N.H.) - all in France; the Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan (N.M.); the Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine (S.H.P.), and Seoul National University Hospital (J.H.K.) - both in Seoul, South Korea; the Section of Radiotherapy and Imaging, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom (R.A.H.); Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC (E.F.B.); the Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany (S.B.); the Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (V.G.); the Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain (B.P.V.); the Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.T.); Janssen Research and Development, Spring House, PA (S.T., Y.K., S.A., N.L.S.); Janssen Research and Development, Beerse, Belgium (K.D.); Janssen Research and Development, Raritan, NJ (S.M.); and the Department of Genitourinary Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston (A.O.S.-R.).; Kean Y; From the Department of Cancer Medicine, INSERM Unité 981, Gustave Roussy, Université Paris-Saclay, Villejuif (Y.L.), the Department of Medical Oncology, Institut de Cancérologie du Gard, Centre Hospitalier Universitaire Caremeau, Nîmes (N.H.), and Montpellier University, Montpellier (N.H.) - all in France; the Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan (N.M.); the Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine (S.H.P.), and Seoul National University Hospital (J.H.K.) - both in Seoul, South Korea; the Section of Radiotherapy and Imaging, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom (R.A.H.); Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC (E.F.B.); the Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany (S.B.); the Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (V.G.); the Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain (B.P.V.); the Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.T.); Janssen Research and Development, Spring House, PA (S.T., Y.K., S.A., N.L.S.); Janssen Research and Development, Beerse, Belgium (K.D.); Janssen Research and Development, Raritan, NJ (S.M.); and the Department of Genitourinary Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston (A.O.S.-R.).; Akapame S; From the Department of Cancer Medicine, INSERM Unité 981, Gustave Roussy, Université Paris-Saclay, Villejuif (Y.L.), the Department of Medical Oncology, Institut de Cancérologie du Gard, Centre Hospitalier Universitaire Caremeau, Nîmes (N.H.), and Montpellier University, Montpellier (N.H.) - all in France; the Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan (N.M.); the Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine (S.H.P.), and Seoul National University Hospital (J.H.K.) - both in Seoul, South Korea; the Section of Radiotherapy and Imaging, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom (R.A.H.); Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC (E.F.B.); the Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany (S.B.); the Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (V.G.); the Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain (B.P.V.); the Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.T.); Janssen Research and Development, Spring House, PA (S.T., Y.K., S.A., N.L.S.); Janssen Research and Development, Beerse, Belgium (K.D.); Janssen Research and Development, Raritan, NJ (S.M.); and the Department of Genitourinary Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston (A.O.S.-R.).; Deprince K; From the Department of Cancer Medicine, INSERM Unité 981, Gustave Roussy, Université Paris-Saclay, Villejuif (Y.L.), the Department of Medical Oncology, Institut de Cancérologie du Gard, Centre Hospitalier Universitaire Caremeau, Nîmes (N.H.), and Montpellier University, Montpellier (N.H.) - all in France; the Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan (N.M.); the Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine (S.H.P.), and Seoul National University Hospital (J.H.K.) - both in Seoul, South Korea; the Section of Radiotherapy and Imaging, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom (R.A.H.); Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC (E.F.B.); the Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany (S.B.); the Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (V.G.); the Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain (B.P.V.); the Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.T.); Janssen Research and Development, Spring House, PA (S.T., Y.K., S.A., N.L.S.); Janssen Research and Development, Beerse, Belgium (K.D.); Janssen Research and Development, Raritan, NJ (S.M.); and the Department of Genitourinary Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston (A.O.S.-R.).; Mukhopadhyay S; From the Department of Cancer Medicine, INSERM Unité 981, Gustave Roussy, Université Paris-Saclay, Villejuif (Y.L.), the Department of Medical Oncology, Institut de Cancérologie du Gard, Centre Hospitalier Universitaire Caremeau, Nîmes (N.H.), and Montpellier University, Montpellier (N.H.) - all in France; the Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan (N.M.); the Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine (S.H.P.), and Seoul National University Hospital (J.H.K.) - both in Seoul, South Korea; the Section of Radiotherapy and Imaging, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom (R.A.H.); Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC (E.F.B.); the Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany (S.B.); the Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (V.G.); the Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain (B.P.V.); the Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.T.); Janssen Research and Development, Spring House, PA (S.T., Y.K., S.A., N.L.S.); Janssen Research and Development, Beerse, Belgium (K.D.); Janssen Research and Development, Raritan, NJ (S.M.); and the Department of Genitourinary Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston (A.O.S.-R.).; Stone NL; From the Department of Cancer Medicine, INSERM Unité 981, Gustave Roussy, Université Paris-Saclay, Villejuif (Y.L.), the Department of Medical Oncology, Institut de Cancérologie du Gard, Centre Hospitalier Universitaire Caremeau, Nîmes (N.H.), and Montpellier University, Montpellier (N.H.) - all in France; the Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan (N.M.); the Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine (S.H.P.), and Seoul National University Hospital (J.H.K.) - both in Seoul, South Korea; the Section of Radiotherapy and Imaging, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom (R.A.H.); Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC (E.F.B.); the Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany (S.B.); the Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (V.G.); the Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain (B.P.V.); the Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.T.); Janssen Research and Development, Spring House, PA (S.T., Y.K., S.A., N.L.S.); Janssen Research and Development, Beerse, Belgium (K.D.); Janssen Research and Development, Raritan, NJ (S.M.); and the Department of Genitourinary Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston (A.O.S.-R.).; Siefker-Radtke AO; From the Department of Cancer Medicine, INSERM Unité 981, Gustave Roussy, Université Paris-Saclay, Villejuif (Y.L.), the Department of Medical Oncology, Institut de Cancérologie du Gard, Centre Hospitalier Universitaire Caremeau, Nîmes (N.H.), and Montpellier University, Montpellier (N.H.) - all in France; the Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan (N.M.); the Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine (S.H.P.), and Seoul National University Hospital (J.H.K.) - both in Seoul, South Korea; the Section of Radiotherapy and Imaging, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom (R.A.H.); Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC (E.F.B.); the Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany (S.B.); the Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (V.G.); the Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain (B.P.V.); the Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.T.); Janssen Research and Development, Spring House, PA (S.T., Y.K., S.A., N.L.S.); Janssen Research and Development, Beerse, Belgium (K.D.); Janssen Research and Development, Raritan, NJ (S.M.); and the Department of Genitourinary Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston (A.O.S.-R.).

Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

Siefker-Radtke, A. O.; Necchi, A.; Park, S. H.; Garcia-Donas, J.; Huddart, R. A.; Burgess, E. F.; Fleming, M. T.; Rezazadeh Kalebasty, A.; Mellado, B.; Varlamov, S.; Joshi, M.; Duran, I.; Tagawa, S. T.; Zakharia, Y.; Akapame, S.; Santiago-Walker, A. E.; Monga, M.; O'Hagan, A.; Loriot, Y.; Tagawa, S.; Flechon, A.; Alexeev, B.; Huddart, R.; Burgess, E.; Rezazadeh, A.; Siefker-Radtke, A.; Vano, Y.; Gasparro, D.; Hamzaj, A.; Kopyltsov, E.; Gracia Donas, J.; Parikh, O.; Schatteman, P.; Culine, S.; Houede, N.; Zanetta, S.; Facchini, G.; Scagliotti, G.; Schinzari, Giovanni; Lee, J. L.; Shkolnik, M.; Fleming, M.; O'Donnell, P.; Stoger, H.; Decaestecker, K.; Dirix, L.; Machiels, J. P.; Borchiellini, D.; Delva, R.; Rolland, F.; Hadaschik, B.; Retz, M.; Rosenbaum, E.; Basso, U.; Mosca, A.; Lee, H. J.; Shin, D. B.; Cebotaru, C.; Moreno, V.; Perez Gracia, J. L.; Pinto, A.; Su, W. -P.; Wang, S. -S.; Hainsworth, J.; Schnadig, I.; Srinivas, S.; Vogelzang, N.; Loidl, W.; Meran, J.; Gross Goupil, M.; Joly, F.; Imkamp, F.; Klotz, T.; Krege, S.; May, M.; Schultze-Seemann, W.; Strauss, A.; Zimmermann, U.; Keizman, D.; Peer, A.; Sella, A.; Berardi, R.; De Giorgi, U.; Sternberg, C. N.; Rha, S. Y.; Bulat, I.; Izmailov, A.; Matveev, V.; Vladimirov, V.; Carles, J.; Font, A.; Saez, M.; Syndikus, I.; Tarver, K.; Appleman, L.; Burke, J.; Dawson, N.; Jain, S.; Schinzari G. (ORCID:0000-0001-6105-7252)

Soares, B; Akapame, S; Cabrera, P; Slee, A; Traina, S; Magno, L

Value in Health. 20(9):A921-A921

Banerji, John S.; Wolff, Erika M.; Slee, April E.; Akapame, Sydney; Dahl, Kathryn; Auerbach, Evan T.; Massman, John D., III; Soung, Michael C.; Pittenger, Kim R.; Corman, John M.

The Journal of Urology. Apr 01, 2016 195(4 Suppl):e400-e401

Alsinnawi, Mazen; Slee, April E.; Banerji, John S.; Dahl, Kathryn L.; Akapame, Sydney; Massman, John D, III; Wolff, Erika M.; Corman, John M.

The Journal of Urology. Apr 01, 2016 195(4 Suppl):e31-e31

Loriot, Y.; Matsubara, N.; Huddart, R.A.; Houede, N.; Laguerre, B.; Guadalupi, V.; Ku, J.H.; Triantos, S.; Akapame, S.; Deprince, K.; Mukhopadhyay, S.; Siefker-Radtke, A.O.

In Annals of Oncology October 2023 34 Supplement 2:S1201-S1201

Siefker-Radtke, A.O.; Matsubara, N.; Park, S.H.; Huddart, R.A.; Burgess, E.F.; Ozguroglu, M.; Perez Valderrama, B.; Triantos, S.; Akapame, S.; Kean, Y.; Deprince, K.; Mukhopadhyay, S.; Loriot, Y.

In Annals of Oncology October 2023 34 Supplement 2:S1199-S1199

Siefker-Radtke AO; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: asiefker@mdanderson.org.; Necchi A; Vita-Salute San Raffaele University, IRCCS San Raffaele Hospital and Scientific Institute, Milan, Italy.; Park SH; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.; García-Donas J; Medical Oncology Department, Fundacion Hospital de Madrid and IMMA Medicine Faculty, San Pablo CEU University, Madrid, Spain.; Huddart RA; Section of Radiotherapy and Imaging, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, UK.; Burgess EF; Medical Oncology Department, Levine Cancer Institute, Charlotte, NC, USA.; Fleming MT; Medical Oncology Department, Virginia Oncology Associates, US Oncology Research, Norfolk, VA, USA.; Rezazadeh Kalebasty A; Department of Medical Oncology, Norton Healthcare, Louisville, KY, USA.; Mellado B; Medical Oncology Department, Hospital Clinic Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain.; Varlamov S; Department of Urologic Oncology, Altai Regional Cancer Center, Barnaul, Russia.; Joshi M; Department of Medicine, Penn State Cancer Institute, Hershey, PA, USA.; Duran I; Department of Medical Oncology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.; Tagawa ST; Division of Hematology and Medical Oncology, Weill Cornell Medical College, New York, NY, USA.; Zakharia Y; Department of Internal Medicine, University of Iowa, Holden Comprehensive Cancer Center, Iowa City, IA, USA.; Akapame S; Janssen Research & Development, Spring House, PA, USA.; Santiago-Walker AE; Janssen Research & Development, Spring House, PA, USA.; Monga M; Janssen Research & Development, Spring House, PA, USA.; O'Hagan A; Janssen Research & Development, Spring House, PA, USA.; Loriot Y; Department of Cancer Medicine, INSERM U981, Gustave Roussy, Université Paris-Saclay, Villejuif, France.

Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

Siefker-Radtke AO; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Necchi A; Department of Medical Oncology, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy.; Park SH; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.; García-Donas J; Fundacion Hospital de Madrid, Madrid, Spain.; Huddart RA; Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, London, UK.; Burgess EF; Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.; Fleming MT; Virginia Oncology Associates, US Oncology Research, Norfolk, VA, USA.; Rezazadeh Kalebasty A; University of California Irvine, Irvine, CA, USA.; Mellado B; Hosptial Clinic Insitut d'Investigacions Biomèdiques August Pi I Sunyer, University of Barcelona, Barcelona, Spain.; Varlamov S; Altai Regional Cancer Center, Barnaul, Russia.; Joshi M; Penn State Cancer Institute, Hershey, PA, USA.; Duran I; Department of Medical Oncology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain.; Tagawa ST; Weill Cornell Medical College, New York, NY, USA.; Zakharia Y; University of Iowa, Iowa City, IA, USA.; Qi K; Janssen Research & Development, Titusville, NJ, USA.; Akapame S; Janssen Research & Development, Spring House, PA, USA.; Triantos S; Janssen Research & Development, Spring House, PA, USA.; O'Hagan A; Janssen Research & Development, Spring House, PA, USA.; Loriot Y; Institut Gustave Roussy, Villejuif, France.

Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101771568 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-1683 (Electronic) Linking ISSN: 26661683 NLM ISO Abbreviation: Eur Urol Open Sci Subsets: PubMed not MEDLINE

Siefker-Radtke, A.O.; Loriot, Y.; Siena, S.; Beato, C.; Duran, M.A. Climent; Varlamov, S.; Duran, I.; Tagawa, S.T.; Geoffrois, L.; Mellado, B.; Semenov, A.; Delva, R.; Lykov, A.P.; Dirix, L.Y.; Akapame, S.; O'Hagan, A.; Tammaro, M.; Mosher, S.; Kang, T.W.; Moreno, V.

In Annals of Oncology September 2020 31 Supplement 4:S584-S585

Banek, S.; Loriot, Y.; Matsubara, N.; Park, S. H.; Huddart, R. A.; Burgess, E. F.; Houede, N.; Laguerre, B.; Guadalupi, V; Ku, J. H.; Triantos, S.; Akapame, S.; Deprince, K.; Mukhopadhyay, S.; Siefker-Radtke, A. O.

ONCOLOGY RESEARCH AND TREATMENT; OCT 3 2023, 46 p94-p94, 1p. Supplement: 5

Stamm AW; Virginia Mason Medical Center, Seattle, Washington.; Akapame S; Axio Research, Seattle, Washington.; Durfy S; Virginia Mason Medical Center, Seattle, Washington.; Kozlowski PM; Virginia Mason Medical Center, Seattle, Washington.

Publisher: Wolters Kluwer Country of Publication: United States NLM ID: 101635343 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-0787 (Electronic) Linking ISSN: 23520779 NLM ISO Abbreviation: Urol Pract Subsets: PubMed not MEDLINE; MEDLINE

Stamm, Andrew; Donahue, Ryan; Dahl, Kathryn; Gaudet, Rochelle; Akapame, Sydney; Corman, John M.

In Urology Practice November 2018 5(6):433-437

Stamm AW; Section of Urology and Renal Transplantation, Virginia Mason Medical Center, Seattle, WA 98101.; Akapame S; Axio Research, Seattle, WA 98121.; Durfy S; Section of Urology and Renal Transplantation, Virginia Mason Medical Center, Seattle, WA 98101.; Du CC; Stony Brook University School of Medicine, Stony Brook, NY 11794-8434.; Kozlowski PM; Section of Urology and Renal Transplantation, Virginia Mason Medical Center, Seattle, WA 98101.

Publisher: Elsevier Science Country of Publication: United States NLM ID: 0366151 Publication Model: Print Cited Medium: Internet ISSN: 1527-9995 (Electronic) Linking ISSN: 00904295 NLM ISO Abbreviation: Urology Subsets: PubMed not MEDLINE

Stamm AW; Section of Urology and Renal Transplantation, Virginia Mason Medical Center, Seattle, WA. Electronic address: Andrew.Stamm@Virginiamason.org.; Akapame S; Axio Research, Seattle, WA.; Durfy S; Section of Urology and Renal Transplantation, Virginia Mason Medical Center, Seattle, WA.; Du CC; Stony Brook University School of Medicine, Stony Brook, NY.; Kozlowski PM; Section of Urology and Renal Transplantation, Virginia Mason Medical Center, Seattle, WA.

Publisher: Elsevier Science Country of Publication: United States NLM ID: 0366151 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-9995 (Electronic) Linking ISSN: 00904295 NLM ISO Abbreviation: Urology Subsets: MEDLINE

Cai J; Janssen Scientific Affairs, LLC, 1125 Trenton-Harbourton Rd, Titusville, NJ, 08560, USA. Jcai22@its.jnj.com.; Delahanty LM; Massachusetts General Hospital Diabetes Center and Harvard Medical School, Boston, MA, USA.; Akapame S; Axio Research, Seattle, WA, USA.; Slee A; Axio Research, Seattle, WA, USA.; Traina S; Janssen Global Services, LLC, Raritan, NJ, USA.

Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 101309314 Publication Model: Print Cited Medium: Internet ISSN: 1178-1661 (Electronic) Linking ISSN: 11781653 NLM ISO Abbreviation: Patient Subsets: MEDLINE

Alsinnawi, Mazen; Slee, April E.; Banerji, John S.; Dahl, Kathryn L.; Akapame, Sydney; Massman III, John D; Wolff, Erika M.; Corman, John M.

In The Journal of Urology April 2016 195(4) Supplement:e31-e31